Roughly 200 million women around the world suffer from endometriosis, a condition that causes tissue from the lining of the uterus to grow in places outside of the uterus.

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) had its price target dropped by HC Wainwright from $22.00 to $12.00 in a note issued to investors on Friday,Benzinga reports. The brokerage ...

New injectable hydrogel regulates immune cell metabolism, reducing inflammation and slowing rheumatoid arthritis progression.

Enlivex recently reported positive interim six (6) months efficacy data from the first stage of its ongoing randomized, multi-country Phase I/II Allocetra™ trial in patients with moderate to severe ...

Announced the U.S. FDA has accepted our Biologics License Application (BLA) seeking full approval of deramiocel for the treatment of Duchenne ...

Cancer is one of the leading causes of death in dogs, with diagnosis ranging from lymphoma to mast cell tumors. A recent ...

Peer-reviewed publication validates efzofitimod's unique anti-inflammatory mechanism of action on macrophages through ...

SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...

Discover how circulating cell-free DNA (cfDNA) is transforming the diagnosis and monitoring of metabolic diseases like ...

Instead of causing inflammation (which can make things worse), the macrophages are instructed ... by applying a 6x multiple to Capricor's 2030E net revenue share of $1.16 billion discounted ...

Inc. , today announced a definitive merger agreement under which Bristol Myers Squibb ("BMS") will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash ...